Confrontation naming is impaired in neurodegenerative conditions like Alzheimer's disease (AD), frontotemporal dementia (FTD) and corticobasal degeneration (CBD). Some behavioural observations suggest a common source of impaired naming across these patient groups, while others ®nd partially unique patterns of naming dif®culty. We hypothesized that a large-scale neural network underlies naming, and that patterns of impaired naming in AD, FTD and CBD re¯ect cortical atrophy that interrupts this network in a manner that is partially shared and partially unique across these patient groups. We tested this hypothesis by correlating naming impairments with voxel-based morphometric (VBM) analyses of cortical atrophy in structural MRIs of 50 patients. We found signi®cant naming de®cits in all patient groups. Naming also correlated with lexical retrieval in all patient groups, including subgroups of patients with FTD. VBM analyses showed signi®cant cortical atrophy, which was shared across AD, FTD and CBD patients in the left lateral temporal cortex; this area correlated with naming accuracy in all groups. Left lateral temporal atrophy thus appears to interfere with a lexical retrieval component of naming in AD, FTD and CBD. Impaired naming also correlated with semantic memory and visual perceptual±spatial functioning in speci®c groups of patients and, correspondingly, naming correlated with cortical atrophy in partially distinct neuroanatomical distributions in AD, FTD, CBD and subgroups of patients with FTD. These partially unique correlation pro®les appear to re¯ect selective interruption of other components of the naming process, including semantic and visual perceptual± spatial functioning. These ®ndings are consistent with the hypothesis that a large-scale neural network supports naming, and that this network is interrupted in several distinct ways in patients with neurodegenerative diseases.
Summary
Confrontation naming is impaired in neurodegenerative conditions like Alzheimer's disease (AD), frontotemporal dementia (FTD) and corticobasal degeneration (CBD). Some behavioural observations suggest a common source of impaired naming across these patient groups, while others ®nd partially unique patterns of naming dif®culty. We hypothesized that a large-scale neural network underlies naming, and that patterns of impaired naming in AD, FTD and CBD re¯ect cortical atrophy that interrupts this network in a manner that is partially shared and partially unique across these patient groups. We tested this hypothesis by correlating naming impairments with voxel-based morphometric (VBM) analyses of cortical atrophy in structural MRIs of 50 patients. We found signi®cant naming de®cits in all patient groups. Naming also correlated with lexical retrieval in all patient groups, including subgroups of patients with FTD. VBM analyses showed signi®cant cortical atrophy, which was shared across AD, FTD and CBD patients in the left lateral temporal cortex; this area correlated with naming accuracy in all groups. Left lateral temporal atrophy thus appears to interfere with a lexical retrieval component of naming in AD, FTD and CBD. Impaired naming also correlated with semantic memory and visual perceptual±spatial functioning in speci®c groups of patients and, correspondingly, naming correlated with cortical atrophy in partially distinct neuroanatomical distributions in AD, FTD, CBD and subgroups of patients with FTD. These partially unique correlation pro®les appear to re¯ect selective interruption of other components of the naming process, including semantic and visual perceptual± spatial functioning. These ®ndings are consistent with the hypothesis that a large-scale neural network supports naming, and that this network is interrupted in several distinct ways in patients with neurodegenerative diseases.
Introduction
Confrontation naming dif®culty is impaired in patients suffering from neurodegenerative diseases such as probable Alzheimer's disease (AD) (Tippett and Farah, 1994; Black, 2000; Kertesz et al., 2000) . Behavioural studies have attempted to establish the sources of naming dif®culty in these patient groups to help with differential diagnosis and severity staging, and to improve our fundamental understanding of the neural basis for this critical element of human communication. However, this body of work has not arrived at a de®nitive conclusion. While cognitive models of naming have pointed out the large variety of possible naming de®cits (Garrett, 1992; Levelt, 1992) , qualitative analyses of naming errors document a relatively limited number of possible errors. The kind of de®cit that is the most common, i.e. no response, is the least informative. In this study, we examined naming dif®culty from a different perspective, i.e. through comparative analyses of correlations between confrontation naming dif®culty and grey matter atrophy using voxel-based morphometry (VBM) analyses of high-resolution structural MRI in patients with impaired naming.
Our model of confrontation naming includes several components: (i) a stimulus such as a visual line drawing must be interpreted; (ii) the concept corresponding to this stimulus must be identi®ed in semantic memory; and then (iii) the name that corresponds to the stimulus must be retrieved and expressed (Garrett, 1992; Levelt, 1992) . Each of these components is quite complex. Lexical retrieval, for example, may involve components such as: (i) selecting the best name from among several possible choices which label objects with overlapping features (e.g.`collie' versus`dog'); (ii) inhibiting alternate names that share many phonological features (e.g. collie' versus`dolly'); (iii) translating an abstract, materialneutral representation of a name into a material-speci®c form; and (iv) assembling the phonological or graphemic elements so that they can be spoken or written (e.g. the written word collie').
Naming has been studied extensively in neurodegenerative diseases such as ADÐpartly because this crucial linguistic process is impaired frequently and early in these illnesses. Naming de®cit is also prominent in the subgroup of FTD patients with a¯uent form of progressive aphasia that is also known as semantic dementia (SD) and, for example, is considered a diagnostic feature of this condition (Snowden et al., 1989; Hodges et al., 1992a; Neary et al., 1998) . In AD, naming dif®culty has been associated with impairments in lexical retrieval (Hodges et al., 1991; Cronin-Golomb et al., 1992) , semantic (Huff et al., 1986; Lambon Ralph et al., 1997; and visual (Tippett and Farah, 1994; Silveri and Leggio, 1996) components of naming. There is partial overlap with the basis for naming dif®culty in FTD, as the de®cit in this group has also been associated with an interruption of lexical retrieval (Weintraub et al., 1990; Lambon Ralph et al., 1998) and semantic (Hodges et al., 1995; Lambon Ralph et al., 2001) processes. Individual case studies and occasional group reports also describe impaired naming in CBD (Kompoliti et al., 1998; Kertesz et al., 2000 ; P. Moore, K. Dennis and M. Grossman, unpublished data). These authors have emphasized the contribution of lexical retrieval and visual perceptual±spatial limitations.
Given the partially shared basis for impaired naming in these neurodegenerative diseases, one hypothesis is that naming dif®culty is due to a de®cit in a single critical component of the naming process such as lexical retrieval. A de®cit in this process is due to cortical dysfunction within a speci®c neuroanatomical distribution that is compromised across patient groups, according to this approach. Quantitative differences in naming accuracy between groups are due to the severity of disease in this crucial brain area. Evidence consistent with this`single de®cit' hypothesis comes from correlation studies that associate naming dif®-culty with impaired lexical retrieval in many groups of patients. For example, several studies have emphasized the importance of dif®culty with lexical retrieval in mildly impaired patients with AD (Chertkow et al., 1992; Hodges et al., 1992b Garrard et al., 1998 Garrard et al., , 2001 ) and CBD (P. Moore, K. Dennis and M. Grossman, unpublished data) . Subgroups of patients with FTD have distinct clinical presentations (Neary et al., 1998; Grossman, 2002 ), yet SD patients, progressive non-¯uent aphasia (PNFA) patients and non-aphasic patients with FTD (NON-APH) with a disorder of social and executive functioning appear to share naming dif®culty and an impairment of lexical retrieval (Weintraub et al., 1990; Croot et al., 1998 ; P. Moore, K. Dennis and M. Grossman, unpublished data) .
Additional support for this`single de®cit' approach comes from MRI studies suggesting shared patterns of cortical atrophy in AD and FTD. Areas of atrophy common to these patients appear to include the temporal neocortex, the frontal neocortex and the hippocampus (Baron et al., 2001; Chan et al., 2001; Galton et al., 2001; Busatto et al., 2003; Karas et al., 2003) . Assuming a single source of naming dif®culty, a correlative MRI study related impaired lexical retrieval in confrontation naming and category naming¯uency tests in a combined group of SD patients and patients with AD to atrophy in a single regionÐthe left anterior temporal cortex ).
An alternate hypothesis is based on the partially distinct pro®les of impaired naming in AD, FTD and CBD. This approach suggests that naming dif®culty in these patient groups is related in part to the unique anatomical distribution of the cortical atrophy seen in these patients. Consistent with this`large-scale network' approach, patients with AD, FTD or CBD have de®cits in partially distinct cognitive components of the naming process. For example, a semantic de®cit appears to contribute more prominently to naming dif®culty in AD and FTD compared with CBD (Huff et al., 1986; Hodges et al., 1995; Lambon Ralph et al., 1997 , while a visual perceptual±spatial de®cit plays a more important role in naming dif®culty in AD and CBD compared with FTD (Tippett and Farah, 1994; Silveri and Leggio, 1996 ; P. Moore, K. Dennis and M. Grossman, unpublished data). Although all FTD subgroups have lexical retrieval dif®culty, careful comparisons suggest qualitative differences in the nature of their lexical retrieval de®cit as well Lambon Ralph et al., 1998; P. Moore, K. Dennis and M. Grossman, unpublished data) . From this perspective, even such components of naming as lexical retrieval and the associated downstream processes are multifactorial in nature and may be compromised in several different ways.
Additional support for this`large-scale network' approach comes from MRI studies suggesting partially distinct patterns of cortical atrophy in AD and FTD. Although direct comparisons of the anatomical distribution of atrophy in AD and FTD have been rare, distributions of atrophy in the temporal lobe appear to be somewhat different in these conditions (Baron et al., 2001; Chan et al., 2001; Galton et al., 2001; Good et al., 2002; Boxer et al., 2003; Busatto et al., 2003; Karas et al., 2003) . Each FTD subgroup also appears to have a partially distinct anatomical distribution of disease, according to in vivo measures such as single photon emission computed tomography (Jagust et al., 1989; Miller et al., 1997) , PET (Grossman et al., 1996b; Turner et al., 1996) and quantitative analyses of atrophy in high resolution MRI studies. Patients with SD thus seem to have prominent left anterior temporal disease (Mummery et al., 2000; Chan et al., 2001; Galton et al., 2001) , while inferior frontal regions of the left hemisphere appear to be most compromised in patients with PNFA (Grossman et al., 1996b; Rosen et al., 2002b; Nestor et al., 2003) and disease in NON-APH patients is said to be focused in frontal regions of the right hemisphere (Miller et al., 1993; Rosen et al., 2002a) . Occasional non-quantitative neuroimaging studies of CBD suggest a distribution of disease primarily involving the parietal cortex, although the temporal and frontal cortical regions also may be atrophic (Caselli et al., 1992; Grisoli et al., 1995; Savoiardo et al., 2000) .
Patients with AD, FTD and CBD have not been directly compared with respect to the neural basis for their naming de®cit. In this study, we correlated VBM analyses of volumetric structural MRI with naming to assess the hypothesis that partially shared and partially unique patterns of cortical atrophy across patient groups account for the pro®les of impaired naming seen in these patients.
Methods

Subjects
We studied 50 patients diagnosed with a neurodegenerative condition at the Department of Neurology at the University of Pennsylvania. Initial clinical diagnosis was established by an experienced neurologist (M.G.) using published criteria. Subsequently, at least two trained reviewers of a consensus committee con®rmed the presence of speci®c diagnostic criteria based on an independent review of the semi-structured history, mental status examination and neurological examination. If the reviewers disagreed in their diagnosis (which occurred in 11% of 70 cases, including patients with other diagnoses not participating in this study), consensus was established through open discussion by the entire committee. These patients and their legal representatives participated in an informed consent procedure approved by the Institutional Review Board at the University of Pennsylvania.
Among the participants, 12 patients were given the diagnosis of AD based on National Institute of Neurological and Communicative Disorders and Stroke Alzheimer's Disease and Related Disorders Association (NINCDS±ADRDA) criteria (McKhann et al., 1984) . This included a progressive syndrome involving prominent episodic memory dif®culty, associated with circumlocutory speech, a visual constructional impairment and/or an executive limitation.
Another 29 patients were given the diagnosis of FTD, according to published criteria (Lund and Manchester Groups, 1994; McKhann et al., 2001) . We also used the consensus mechanism described above to establish subgroup diagnosis. The subgroups were based on published criteria (Neary et al., 1998) , which have been modi®ed to improve reliability Price et al., 2001 ). We studied 15 FTD patients with a progressive form of aphasia and 14 FTD patients with a non-aphasic pattern of cognitive and social impairment. One aphasic subgroup consisted of patients presenting with a¯uent form of progressive aphasia, also known as SD (n = 8). This was characterized by¯uent and circumlocutory spontaneous speech, which may be empty in content, and is associated over time with dif®culty understanding single words. Since these patients were relatively early in the course of their disease, they had a prominent naming de®cit without widespread dif®culty understanding single words. Another progressive aphasic subgroup of FTD patients consisted of those presenting with PNFA (n = 7). These patients had effortful speech, which may be associated with dysarthria and impaired grammatical comprehension, but relatively good single word comprehension. The NON-APH subgroup of FTD patients (n = 14) presented with social and behavioural dif®culties, and a limitation of executive functioning.
Finally, nine patients were given the clinical diagnosis of CBD based on clinical-pathological studies reported in the literature and our own autopsy series (Rinne et al., 1994; Grimes et al., 1999; Riley and Lang 2000; Forman et al., 2002) . These patients had progressive cortical sensory loss, apraxia and/or a lateralized extrapyramidal disorder (unilateral limb rigidity, myoclonus, dystonia, alien hand syndrome, gait dif®culty and/or axial rigidity, but minimal resting tremor).
The initial clinical diagnosis of a neurodegenerative disease was consistent with the results of serum studies, structural imaging studies such as MRI or CT, studies of CSF (when available) and clinical functional neuroimaging studies such as single photon emissions computerized tomography (SPECT) or PET (these studies were not available to the consensus committee). Exclusion criteria included the presence of other neurological conditions such as stroke or hydrocephalus, primary psychiatric disorders such as depression or psychosis, or a systemic illness that can interfere with cognitive functioning. Most of these patients were taking a ®xed dosage of an acetylcholinesterase inhibitor (e.g. donepezil, rivastigmine or galantamine). Some of these patients may have been medicated with a low dosage of a non-sedating anti-depressant (e.g. serotoninspeci®c re-uptake inhibitors such as sertraline) or an atypical neuroleptic agent (e.g quetiapine), as indicated clinically, but none of the patients demonstrated any evidence of sedation suggesting over-medication. (Folstein et al., 1975) Confrontation naming in these patients was compared with cohorts of 25 healthy older control subjects who were closely matched in age and education to each group of patients. The performance of each patient was converted to a Z-score based on each group's matched control subjects; we compare these normalized Z-scores statistically across the patient groups in Results below. It may be noted that the subgroups of control subjects did not differ statistically in their naming performance. The patients were participating in a longitudinal protocol. For the purpose of the present study, we selected the naming performance dataset closest in time to the MRI (naming data were obtained on the same day as the MRI in the overwhelming majority of patients) and these data were typically obtained early in the course of disease. Imaging data in these patients was compared with 12 right-handed, healthy, control subjects who were matched for age [mean (TSD) = 68.5 (T9. 
Cognitive materials and procedure
We administered several measures to assess confrontation naming and the major processes thought to contribute to naming. We selected a validated measure corresponding most closely to each component of naming that we hypothesized. The patients were offered rest breaks between tasks as necessary during the performance of these measures.
Confrontation naming
To assess confrontation naming (Morris et al., 1989) , we used an abbreviated version of the Boston naming test (Kaplan et al., 1983) , which was thought to be representative of the full protocol. Each subject was asked to name orally each test stimulus (n = 15). All visual stimuli were black-and-white line drawings, and target names were divided equally between high frequency, mid-frequency and low frequency items. Patients were given as much time as they needed to respond.
Lexical retrieval
To assess semantically-guided lexical search, retrieval and associated downstream processes such as phonological assembly and articulation, patients were asked to name orally as many different words as possible belonging to a target semantic category, i.e. ANIMALS (Mickanin et al., 1994) . They were given 60 s to complete this task. We report the number of unique words meeting the category criterion in this time span. Two FTD patients (one SD patient and one NON-APH patient) did not complete this task.
Semantic category membership judgement
To assess semantic memory with a simple task that required little expression and minimized executive resource demands, patients were asked to judge the semantic category membership of 48 individually presented stimuli in response to a simple probe (`Is it an X?') (Grossman et al., 1996a) . One target category was natural (VEGETABLES) and one manufactured (TOOLS); half of the stimuli in each category were targets and half foils, and half of each category of stimuli were printed words and half colour photos (matched for frequency, familiarity and visual complexity across categories). Stimuli were presented in a manner blocked by category and material. Patients were given as much time as they needed to complete the task. Performance on this task has been validated by behavioural and SPECT correlation studies in AD patients with impaired semantic memory (Grossman et al., 1997) . Two FTD patients (both NON-APH patients) and one CBD patient did not complete this task.
Visual±spatial functioning
To assess visual perceptual±spatial functioning (Morris et al., 1989) in a manner involving a constructional element, patients were asked to copy four geometric designs graded according to their perceptual± spatial complexity. Performance was evaluated on an 11-point scale.
One patient in each group (including one NON-APH FTD patient) did not complete this task. 
Imaging procedure
All images were acquired by a GE Horizon Echospeed 1.5 T MRI scanner (GE Medical Systems, Milwaukee, WI, USA). Each study began with a rapid sagittal T1-weighted image to determine patient position. High resolution T1-weighted 3D spoiled gradient echo images were then acquired with TR (repetition time) = 35 ms, TE (echo time) = 6 ms, slice thickness = 1.3 mm,¯ip angle = 30°, matrix size = 128 Q 256, and a rectangular FOV (®eld of view) giving an inplane resolution of 0.9 Q 0.9 mm. The brain volumes were normalized by registration to the T1 template (Evans et al., 1993) of 305 averaged brain volumes in SPM99 (Frackowiak et al., 1997) using 12-parameter af®ne registration, non-linear registration using 12 non-linear iterations and 7 Q 8 Q 7 basis functions. The brains were normalized to Talairach and Tournoux brain coordinates (Talairach and Tournoux, 1988) . We examined the results of both unmodulated and modulated routines, but a comparison found no regional differences between these techniques. We report below the results from the unmodulated analysis. We used VBM to analyse brain volumes (Ashburner and Friston, 2000) . SPM99 was used to segment the brain volumes into four tissue types (grey matter, white matter, CSF and other). Based on a priori MRI information, the segmentation algorithm in SPM99 calculates a Bayesian probability for each voxel of each tissue group in the volume. We inspected each slice of each segmented volume to ensure that no voxels from the dural sinuses or other adjacent nonbrain structures were misclassi®ed as grey matter (Good et al., 2001; Karas et al., 2003) . Lastly, using SPM99, the grey matter volume was smoothed with a 12 mm FWHM (full width at half maximum) Gaussian ®lter to minimize individual gyral variations.
SPM99 was used for all statistical analyses. This included a two sample t-test routine to compare the grey matter volume of each patient group to the control group of 12 healthy seniors, and to assess relative grey matter atrophy across patient groups by comparing pairs of contrasts involving each patient group and the healthy seniors. A proportional analysis threshold was used to include only voxels with b40% of the grand mean value. Implicit masking was used to ignore zeros and global calculation was based on the mean voxel value. We set our statistical threshold for the atrophy studies of each patient group relative to control subjects at a value of P < 0.0001. We did not correct for multiple comparisons in this and other analyses due to the hypothesis-driven nature of the statistical tests. Moreover, the small size of the voxels would have made a Bonferroni-like statistical correction too conservative. Instead, for all analyses, we accepted only clusters comprised of b100 adjacent voxels because this would also demonstrate a consistent effect in a particular neuroanatomical distribution (Forman et al., 1995) . The between group comparisons of grey matter atrophy derived from pairs of patient±control contrasts were set at a statistical threshold of P < 0.001. The correlation analyses involved a regression of the confrontation naming Z-score on grey matter atrophy derived from the contrast of each patient group with the elderly control subjects. We set a statistical threshold for these analyses at P < 0.001. We focused on the signi®cant correlations of naming and cortical volume that correspond to areas of signi®cant grey matter atrophy. These correlations occur in demonstrably abnormal brain regions, and it is these correlated voxels that are likely to re¯ect interruptions of the large-scale neural network underlying naming. In comparison, naming±cortical correlations involving brain regions without signi®cant grey matter atrophy are dif®cult to interpret unequivocally as these correlations are in regions where the large-scale neural network for naming is less likely to be compromised.
Results
Behavioural analyses of naming performance
Confrontation naming accuracy is summarized in Table 1 . As can be seen, the average naming de®cit in AD, FTD and CBD patient groups differed signi®cantly from older control subjects' performance, using a criterion of Z < ±1.96 (signi®cant at the P < 0.05 level). However, an analysis of variance (ANOVA) did not reveal a difference in naming accuracy across patient groups [F(2,47) = 0.38; ns]. All three FTD subgroups were signi®cantly impaired in their confrontation naming relative to the performance of healthy seniors as well (at least at the P < 0.05 level, according to Z-score distributions). Although there was no statistical difference between FTD patient subgroups in their confrontation naming [F(2,26) = 0.48; ns], Table 1 shows that SD patients were the most impaired FTD subgroup. SD patients were also more impaired than AD patients and CBD patients. An evaluation of individual patient performance pro®les revealed that 32 (64%) of the patients differed signi®cantly from older control subjects in their naming accuracy at the P < 0.05 level (Z < ±1.96). This included seven (58%) of the AD patients, four (44%) of the CBD patients and 21 (72%) of the FTD patients [including seven (88%) of the SD patients, four (56%) of the PNFA patients and 10 (71%) of the NON-APH patients]. These ®ndings con®rm previous observations that confrontation naming is widely compromised in patients with these neurodegenerative diseases and that confrontation naming is particularly impaired in the SD subgroup of patients with FTD. Table 1 also summarizes the performance of the patient groups with regard to measures of each of the major cognitive components thought to contribute to confrontation naming. All patient groups differed from control subjects in their lexical retrieval performance at the P < 0.01 level (according to Z-score distributions), . Inspection of individual patient performance pro®les revealed that 42 (88%) of the patients differed signi®cantly from older control subjects in their lexical retrieval performance at the P < 0.05 level (Z < ±1.96). This included all 12 (100%) of the AD patients, seven (78%) of the CBD patients and 23 (85%) of the 27 FTD patients who performed this task (including six (86%) of the seven SD patients, seven (100%) of the PNFA patients and 10 (77%) of the 13 NON-APH patients). None of the patient groups differed signi®cantly from the older control subjects in their performance on the simple measure of semantic memory we administered (including each of the FTD patient subgroups). Nevertheless, an ANOVA revealed a difference between groups [F(2,46) = 5.44; P < 0.01]. AD patients (33% of whom were impaired according to individual Z-score analyses) differed signi®-cantly from FTD patients and CBD patients in their semantic memory performance at the P < 0.05 level according to a Newman±Keuls procedure. CBD patients differed signi®cantly from older control subjects in their visual±spatial performance at the P < 0.01 level (according to the Z-score distribution), although AD patients and FTD patients (and each of the FTD patient subgroups) did not differ from control subjects. We also found a difference between groups on the visual±spatial measure [F(2,46) = 24.69; P < 0.001]. CBD patients (seven of whom were impaired according to individual Z-score analyses) differed signi®cantly from AD patients and FTD patients in their visual±spatial performance at least at the P < 0.05 level according to a Newman±Keuls procedure. A correlation analysis is summarized in Table 2 . As can be seen, confrontation naming accuracy correlated with lexical retrieval performance in AD, FTD and CBD. We also saw a correlation between naming accuracy and lexical retrieval in each of the FTD subgroups. We also found that CBD patients show a correlation between confrontation naming and visual±spatial functioning. In FTD, confrontation naming accuracy also correlated with semantic memory performance.
These ®ndings con®rmed signi®cant naming dif®culty in mildly-to-moderately demented patients with AD, CBD and FTD. Moreover, lexical retrieval was signi®cantly impaired across all patient groups and correlated with impaired confrontation naming in each patient group. These observations emphasize the importance of lexical retrieval in these patients and suggest that impaired naming may be due to the disruption of a single component of the naming process across groups of patients with different neurodegenerative diseases. However, semantic memory appeared to play a role in naming dif®culty in FTD and visual±spatial functioning contributed to the naming de®cits of CBD patients. These ®ndings are more consistent with the hypothesis that various components of the naming process may be disrupted differentially in neurodegenerative diseases; this may result in partially distinct patterns of impaired naming across these groups of patients. Indeed, the lexical retrieval component of naming and associated downstream processes can be compromised in many ways.
VBM analyses of cortical atrophy
The anatomical loci of peak grey matter atrophy in patients with AD, FTD and CBD, and the extent of the associated clusters are summarized in Table 3 . These ®ndings showed partially overlapping distributions of cortical atrophy across the patient groups. AD patients demonstrated signi®cant grey matter atrophy in the bilateral temporal, left frontal and right parietal regions. FTD patients also showed cortical atrophy in the bilateral temporal and frontal brain regions. CBD patients showed grey matter atrophy in the bilateral temporal and frontal regions as well as the bilateral parietal regions. As illustrated in Fig. 1A , patients with AD, FTD and CBD showed overlapping distributions of signi®cant cortical atrophy in the lateral temporal cortex of the left hemisphere. There was also a very small area of overlapping signi®cant atrophy in the right inferolateral temporal cortex (11 voxels). An area of cortical atrophy common to AD, FTD and CBD suggests the possibility that the basis for impaired naming may be shared in part across these patient groups.
We also examined cortical atrophy in AD, FTD and CBD patient groups compared with each of the other patient groups. These group-by-group contrasts, summarized in Table 3 and illustrated in Fig. 1 , emphasized differences in the distribution of grey matter atrophy across these patient groups. Consider ®rst the pattern of atrophy in AD compared with FTD and CBD. Relative to FTD, AD patients have signi®cantly greater atrophy in the bilateral posterolateral temporal-parietal and lateral occipital regions (Fig. 1B) . We also observed signi®cantly greater atrophy in the left hippocampus in AD relative to FTD (not shown). Relative to CBD, AD patients have greater atrophy in a left anterior and ventral temporal distribution (Fig. 1C) . AD patients also have greater atrophy than CBD patients in the left anterior cingulate cortex (not shown). Atrophy in FTD also differed from that seen in AD and CBD. FTD patients have relatively greater atrophy in the right prefrontal (Fig. 1D ) and left medial frontal (not shown) regions compared with AD patients. Relative to CBD, FTD patients have greater atrophy in the left anterior temporal (Fig. 1E ) and the left anterior cingulate (not shown) regions. CBD patients showed greater atrophy in bilateral parietal and right frontal and temporal regions compared with AD patients (Fig. 1F) . Compared with FTD patients, CBD patients have greater atrophy in bilateral temporal-parietal regions (Fig. 1G) , including the medial parietal cortex (not shown). These partially distinct patterns of cortical atrophy are consistent with the hypothesis that the neural basis for impaired naming may differ in part across these patient groups. We performed similar analyses of grey matter atrophy in subgroups of patients with FTD. These ®ndings are summarized in Table 4 . As can be seen, signi®cant grey matter atrophy was evident in several areas of the left temporal cortex in SD. Patients with PNFA also showed signi®cant cortical atrophy in portions of the left temporal lobe, as well as signi®cant grey matter atrophy in several left frontal regions. NON-APH patients with FTD also demonstrated some left temporal grey matter atrophy, as well as cortical atrophy in a right frontal distribution. Figure 2A illustrates the distribution of grey matter atrophy in these FTD subgroups. An area of signi®cant cortical atrophy shared across all FTD patients was seen in the left anterior temporal cortex; this is consistent with the possibility that disruption of a single component of the naming process may explain naming dif®culty in all subgroups of patients with FTD.
Areas of signi®cant cortical atrophy that differed across subgroups of FTD patients are summarized in Table 4 . For example, Fig. 2B shows that SD patients have signi®cant grey matter atrophy in the left posterolateral temporal cortex relative to PNFA patients. Figure 2D illustrates the distribution of signi®cant grey matter atrophy in PNFA relative to SD in the frontal cortex of the right hemisphere. Other pairwise FTD subgroup comparisons are shown in Fig. 2 . These differences suggest that confrontation naming dif®culty in subgroups of FTD patients may be due to partially distinct sources of impairment.
Correlations between confrontation naming accuracy and cortical volume Table 5 summarizes the coordinates of the peak foci of signi®cant correlations between confrontation naming performance and grey matter volume in patients with AD, FTD and CBD. In AD, signi®cant correlations between cortical volume and confrontation naming were found in the left lateral temporal cortex and the left anterior cingulate cortex. Fig. 3 shows the distribution of areas of signi®cant correlation between naming and cortical volume, which overlap with areas of signi®cant cortical atrophy. The correlations between naming performance and grey matter volume corresponded to areas of signi®cant cortical atrophy in an anterior-lateral temporal distribution of the left hemisphere, as well as a small inferolateral temporal area in the right hemisphere (Fig 3A) . Table 5 shows that patients with FTD have signi®cant correlations between confrontation naming accuracy and grey matter volume in the bilateral anterior temporal and bilateral frontal regions. The correlation between naming and cortical volume in FTD corresponds to the area of signi®cant cortical atrophy in the left anterior-lateral temporal cortex, as well as small areas in the right temporal cortex and left frontal cortex (Fig. 3B ).
Table 5 also shows that naming performance correlated with grey matter volume in CBD in the bilateral frontal and temporal cortices. These naming-cortical correlations correspond to areas of signi®cant cortical atrophy in CBD in small areas of the frontal and temporal cortex bilaterally (Fig. 3C ). These observations are consistent with the hypothesis that the neural basis for impaired naming partially overlaps in lateral aspects of the left temporal cortex across patients with AD, FTD and CBD. Unique correlations in each patient group also appear to provide evidence consistent with the claim that partially distinct components of the large-scale neural network for naming are interrupted in patients with neurodegenerative diseases.
We also examined patterns of correlation between confrontation naming performance and cortical volume in subgroups of patients with FTD. Table 5 summarizes the coordinates of the peak foci of signi®cant correlation between confrontation naming and grey matter volume in these patients. In SD, signi®cant correlations were seen in bilateral temporal cortex. Fig 4A shows the area of correlation between naming and cortical volume in SD that overlaps with signi®cant cortical atrophy. This was in the left lateral temporal region. Table 5 indicates that the anatomical distribution of signi®cant naming-volume correlation in PNFA was in the frontal and temporal areas bilaterally. The naming-volume correlations overlapping with areas of signi®cant grey matter atrophy in PNFA were in the left anterior temporal cortex, as well as the inferior, orbital, dorsolateral prefrontal and premotor portions of the left frontal lobe (Fig. 4B) . In NON-APH patients, signi®cant naming-volume correlations were seen in bilateral frontal cortex extending to the anterior cingulate cortex and in the left temporal and parietal regions (Table 5 ). Signi®cant naming-volume correlations overlapping with regions of signi®cant cortical atrophy in NON-APH (Fig. 4C) were in the left anterior temporal cortex and the right dorsolateral prefrontal cortex. These distinct naming-cortical correlations are consistent with the hypothesis that a large-scale neural network for naming is interrupted in several unique ways in subgroups of patients with FTD.
Discussion
Naming is a complex process involving components such as interpreting a visual stimulus, identifying the corresponding concept in semantic memory, and selecting and expressing the name that best labels this concept. Since naming is so complex, a neurobiologically valid model of naming is likely to require converging evidence from multiple sources. This may include: neuroanatomical observations based on studies of stroke patients (Hillis et al., 2001 ); functional neuroimaging studies of healthy subjects using PET (Howard et al., 1992; Whatmough et al., 2002) or functional MRI (Smith et al., 2001; Simon et al., 2002) ; ®ne-grained temporal observations of the naming process with electrocortical studies of naming during the presurgical evaluation of epilepsy patients (Ojemann and Schoen®eld-McNeill, 1999; Crone et al., 2001) ; and event-related scalp potential studies of healthy subjects (Indefrey and Levelt, 2000) . The present study examines the nature of naming dif®culty in patients with AD, FTD and CBD, and the relationship between these naming de®cits and the patterns of cortical atrophy seen in these patients. We argue below that naming is supported by a large-scale neural network involving multiple cortical regions. Our observations are consistent with the hypothesis that this network is interrupted in a manner which is partially shared across these patient groups and in a manner that is partially unique to each patient group. This yields a pattern of naming dif®culty that includes a component common to all groups, namely lexical retrieval, as well as components distinct to each patient group involving speci®c aspects of retrieval as well as impairments of semantic memory and visual perceptual±spatial functioning.
Behavioural observations of impaired naming: partially shared and partially distinct patterns of naming dif®culty
We found that naming dif®culty is signi®cantly compromised in AD, FTD and CBD. This is consistent with many previous observations of naming performance in these patient groups. Moreover, the level of naming dif®culty was quantitatively equivalent across groups. One factor appeared to contribute to naming dif®culty across all three patient groups: consistent with previous observations, naming accuracy correlated with lexical retrieval in AD (Hodges et al., 1991; Cronin-Golomb et al., 1992) , in FTD Lambon Ralph et al., 1998) and in CBD (P. Moore, K. Dennis and M. Grossman, unpublished data). This suggests that a single component, i.e. lexical retrieval, may play a role in naming dif®culty shared across patient groups. It is also apparent in our data and in previously published work that these patients demonstrate some qualitatively distinct features in their impaired naming. Consider ®rst patients with AD. Only lexical retrieval showed a statistically signi®cant correlation with naming dif®culty in the AD patients participating in this study. This differed from the pattern seen in FTD and CBD, where additional factors appeared to contribute to their naming de®cit. Although some work has related semantic memory to impaired naming in AD (Huff et al., 1986; ; Lambon Ralph et al., 1997), we may not have observed a naming-semantic correlation in these AD patients because of their degree of dementia and heterogeneity in semantic functioning within the AD group (Grossman et al., 1996a (Grossman et al., , 1997 . We adopted the strategy of studying AD patients with mild-to-moderate dementiaÐeven though this limits the ability to generalize our ®ndings across the entire spectrum of AD severityÐto allow matching for severity with groups of FTD and CBD patients. With this measure of semantic memory, we also minimize the potential confounds associated with task-related resource demands. In FTD, by comparison, naming accuracy appeared to correlate with lexical retrieval as well as with the semantic component of naming. This has been seen in other work ( Naming in CBD correlated with lexical retrieval and performance on a measure of visual perceptual±spatial functioning (P. Moore, K. Dennis and M. Grossman, unpublished data). These ®ndings suggest that impaired naming may have qualitatively distinct features in AD, FTD and CBD. While the measures of lexical retrieval, semantic and visual perceptual±spatial functioning were selected to re¯ect each of these components of naming, our observations may be limited by the fact that each was assessed by a single measure and thus may not capture its full scope in the naming process. Moreover, the numbers of patients we examined in each group was relatively small. This limits the statistical treatments of the data, suggests caution in generalizing our ®ndings and emphasizes the importance of additional work with larger and more varied groups of these patients. With these caveats in mind, our observations are consistent with the hypothesis that a de®cit in lexical retrieval and associated downstream processes is common to all patients suffering from AD, FTD or CBD, and that this component of naming may play a role in the naming dif®culty that is shared by these patients. Further, the behavioural ®ndings suggest some unique aspects of impaired naming in each of these neurodegenerative diseases, consistent with the hypothesis that a large-scale neural network for naming is interrupted in several distinct ways in these patients.
Our observations also con®rm a statistically signi®cant naming de®cit in SD, PNFA and NON-APH subgroups of patients with FTD. While clinical observations and empirical studies emphasize the profound naming impairment in patients with SD (Snowden et al., 1989; Hodges et al., 1992a; Neary et al., 1998) , naming dif®culty is also evident in PNFA and NON-APH patients (Weintraub et al., 1990; Croot et al., 1998 ; P. Moore, K. Dennis and M. Grossman, unpublished data). SD patients showed the greatest naming impairment and almost all the individual SD patients had a signi®cant naming de®cit. However, we were not able to con®rm a statistically greater de®cit in SD than other patients with FTD due to the relatively small number of patients participating in this study.
We also examined whether the naming de®cit in FTD subgroups is due to an impairment of a single critical component of the naming process or to the interruption of different components of a large-scale neural network underlying naming. SD, PNFA and NON-APH patients all showed a correlation with lexical retrieval, suggesting that a single component of naming is compromised across all three FTD subgroups. Previous work has also emphasized the contribution of other cognitive components to impaired naming in FTD subgroups. For example, patients with SD have semantic memory impairments that appear to play a role in their naming de®cit (Hodges et al., 1995; Lambon Ralph et al., 1998 ; P. Moore, K. Dennis and M. Grossman, unpublished data). We may not have observed this because the SD patients participating in the present study were early in the course of their disease and had a de®cit in understanding occasional words that was not suf®ciently extensive to be detected by a standard, group-based, semantic protocol (Lambon . Semantic dif®culty may also be present in PNFA and NON-APH patientsÐas manifested in their respective de®cits in verb knowledge and social knowledge (Bak et al., 2001; Grossman et al., 2003; Wood and Grafman, 2003; P. Moore, K. Dennis and M. Grossman, unpublished data) . In this context, we may have seen a correlation of naming with semantic memory across all FTD patients, but not in each subgroup either due to the relatively small number of participants in each subgroup or because of the different kinds of semantic memory that may be compromised in these subgroups. The de®cit in NON-APH patients may depend to some extent on their pattern of nonaphasic cognitive impairment, such as the presence of distractibility and other non-speci®c test-taking issues unrelated to the naming process per se (Rahman et al., 1999; Perry and Hodges, 2000; Rosen et al., 2002a) . PNFA patients also appear to have some executive de®cits that may limit their naming (Rhee et al., 2001) . Finally, it is important to emphasize that lexical retrieval itself is a complex process involving multiple components. Despite the overwhelmingly common occurrence of a speci®c kind of naming de®cit, i.e. failure to retrieve a word, which super®cially appears to be identical in all groups of patients, the neurodegenerative process may interrupt different aspects of retrieval and expression in a large-scale neural network for naming in subgroups of FTD patients. This possibility can be examined by looking for different cognitive-cortical correlative patterns in patients with super®cially similar pro®les of impaired naming. We discuss below cortical atrophy in neurodegenerative diseases and the relationship of this atrophy to their naming de®cit.
Correlations of naming dif®culty with cortical atrophy: a single component of naming compromised across all patient groups
The present study sought to take advantage of partially shared and partially distinct patterns of naming dif®culty across neurodegenerative diseases to learn about the neural basis for confrontation naming. In particular, we tested the hypothesis that qualitative similarities in language and cognition related to naming are due in part to patterns of cortical atrophy shared across AD and FTD, while qualitative differences in the language and cognitive components of naming are also associated with the partially distinct patterns of cortical atrophy seen in AD and FTD. We add to these observations the ®rst quantitative study of grey matter atrophy in CBD.
While an important advantage of this approach is the prominent anomia in these patients, one shortcoming is the absence of histopathologically con®rmed diagnosis. Clinical diagnosis is a marker for regional cortical abnormality that interferes with the naming process, and additional work will be needed in the future to relate naming de®cits more directly to histopathological abnormalities. We used VBM analyses of structural MRI to identify the neuroanatomical distribution of grey matter atrophy in neurodegenerative diseases. Although other techniques are available, imaging studies of regional cortical atrophy have generally adopted one of two approaches: (i) a region-ofinterest (ROI) analysis; or (ii) VBM. Few direct comparisons of VBM and ROI approaches have been published (Good et al., 2002) , and discrepancies may be due to several differences between techniques that emphasize their relative advantages and disadvantages. The VBM technique does not allow the careful preservation of gyral and sulcal patterns of individual patients which can be achieved with an ROI approach, even though there is signi®cant variability in the sulcal patterns across individuals that may be dif®cult to interpret with the ROI approach (Steinmetz and Seitz, 1991) . Careful histological analyses also underline the poor correspondence between gross sulcal anatomy and microscopicallyde®ned architectonic boundaries (Amunts et al., 1999) . These individual anatomical features are blurred in VBM analyses that normalize each brain to a template and smooth the images in preparation for statistical analysis of group data. Although labour-intensive and time-consuming, the ROI technique is less reliable than a computer-based, fullyautomated VBM approach. There are potential problems associated with the automatic identi®cation of tissue types during extraction of the brain from the skull prior to segmentation (Good et al., 2001; Karas et al., 2003) . The brain to which experimental subjects are normalized can be vexing: since the most widely used average brain uses young adults (Evans et al., 1993) , greater deformation is required when studying the brains of elderly subjects. Potential solutions include using a`local' template composed of the participants in a study, normalizing with a high dimensional algorithm, or implementing a deformation-based approach to normalization (Gee and Haynor, 1999; Good et al., 2001; Karas et al., 2003) Ðalthough these are not problem-free,. Other shortcomings of VBM have been detailed elsewhere (Ashburner and Friston, 2000; Baron et al., 2001; Good et al., 2001; Karas et al., 2003) . We attempted to minimize some of these issues by: (i) using age-matched seniors as a reference group; (ii) by inspecting each slice of each segmented image of each patient for inaccurately labelled voxels; and (iii) by performing direct comparisons of cortical atrophy across agematched patient groups that take into account a common reference group. A ®nal issue is that cortical atrophy may not always re¯ect the full extent of functional cortical disease identi®ed by other techniques such as PET (Che Âtelat et al., 2003) . Additional work is needed to determine whether discrepancies between techniques re¯ect equally necessary components of a large-scale neural network supporting a cognitive function.
With these caveats in mind, the results of the present study are consistent with the claim that naming dif®culty is due in part to the interruption of a single neural component across all groups of patients. For example, we found an area of cortical atrophy that is common to AD, FTD and CBD, i.e. the lateral temporal cortex in the left hemisphere. A very small area of the right inferolateral temporal cortex also shared atrophy across groups. Dorsolateral prefrontal regions of the left hemisphere of these patient groups with cortical atrophy were adjacent to each other, although there was no overlap across all three groups.
The observation of signi®cant atrophy on its own permits only very limited inferences about brain±behaviour relationships in neurodegenerative diseases. Demented patients have many different kinds of cognitive de®cits, and any of these may be related to an area of cortical atrophy. We therefore performed direct correlations between naming performance and cortical volume. We found that confrontation naming correlates with cortical volume in the left lateral temporal lobe of patients with AD, FTD and CBD. This is somewhat consistent with previous work showing a correlation between confrontation naming and the left anterior temporal cortex in a combined group of AD patients and SD patients . To con®rm that a speci®c anatomical distribution of correlation between naming and cortical volume contributes to the naming impairment of these patients, we constrained our inferential reasoning further by requiring that the correlation correspond to a region of signi®cant cortical atrophy. With this constraint, we observed naming-cortical volume correlations in a left lateral temporal distribution in each patient group which was also signi®cantly atrophic. Based on the observations that (i) naming dif®culty correlated with impaired lexical retrieval in groups of patients with AD, FTD and CBD, (ii) there was a correlation between naming and cortical volume in left lateral temporal cortex in all three groups of patients and (iii) left temporal cortex was atrophic in the area of signi®cant correlation in all of these patients, it seems reasonable to infer that this left lateral temporal region contributes to naming in AD, FTD and CBD. Since lexical retrieval appears to be the only component associated with naming in all three patient groups, it is likely that left lateral temporal cortex plays a role in the lexical retrieval component of naming.
Much work has associated naming with the left temporal lobe. Naming dif®culty has been observed following focal ischaemic insult to the left temporal lobe (Benson, 1979; Kohn and Goodglass, 1985; Goodglass, 1993) . Functional neuroimaging studies in healthy adults have shown activation of the left temporal cortex during naming (Howard et al., 1992; Mummery et al., 1998; van Turennout et al., 2000; Whatmough et al., 2002; Burgund et al., 2003) . One PET study demonstrated activation in healthy subjects during naming of the left lateral temporal cortex, which was in the same anatomical distribution as patients with structural insult causing a lexical retrieval de®cit during naming (Damasio et al., 1996) . Based on the observation that semantic memory was preserved in their patients, these investigators hypothesized that the left lateral temporal cortex serves as an interface between the neural representation of a concept and the abstract representation of its name. The left lateral temporal area in this study is very similar to the anatomical distribution of the correlation we observed. It is also possible to speculate that the inferolateral temporal cortex of the right hemisphere contributed to the lexical retrieval component of naming dif®culty across these patients, although the very small volume of tissue implicated in this region should be borne in mind. The right temporal cortex has been associated with sparse representations of word meaning (Beeman et al., 1994) and may contribute to retrieval by helping to limit the scope of the search for a target concept. Regardless of the contribution to naming played by lateral temporal cortex, these ®ndings suggest that the impairment of one component of naming is likely to be shared across patients with AD, FTD and CBD.
Correlations between naming and cortical atrophy: multiple interruptions of a large-scale neural network result in partially distinct patterns of impaired naming in AD, FTD and CBD While the observations described above lend support to thè single component' hypothesis of impaired naming, several ®ndings suggest that this may not fully explain naming dif®culty in these patients. Consider in more detail AD patients, where impaired naming correlated only with lexical retrieval. We found a signi®cant correlation between naming and cortical volume in the left lateral temporal cortex in AD as well as in FTD, and a direct comparison showed that AD patients have signi®cantly greater atrophy in the left lateral temporal cortex than FTD patients. Other imaging and autopsy work has shown signi®cant atrophy in this anatomical distribution in AD as well (Grady et al., 1988; Arnold et al., 1991; Haxby et al., 1990; Johnson et al., 1993; Karbe et al., 1994; Alsop et al., 2000; Baron et al., 2001; Busatto et al., 2003) . The`single component' hypothesis would predict that naming should be more impaired in AD than FTD since left lateral temporal atrophy is greater in AD than in FTD. In fact, this was not found: naming dif®culty was statistically equivalent in AD and FTD. Similarly, the lexical retrieval de®cit was equivalent statistically across these patient groups. While the left lateral temporal cortex may contribute to the lexical retrieval component of naming, the severity of disease in this area does not appear to predict the relative severity of the impairment in naming or lexical retrieval.
Additional evidence for a multifactorial approach to naming comes from the observation of different behavioural correlation pro®les in FTD and CBD, and the distinct patterns of signi®cant cortical atrophy across these patient groups. Consider in this context patients with FTD. The pattern of correlations between naming and cortical atrophy appears to re¯ect a combination of the pro®les seen across FTD subgroups. SD, PNFA and NON-APH patients all showed a signi®cant correlation between confrontation naming accuracy and lexical retrieval, although correlations between naming and cortical volume showed a distinct pro®le in each subgroup. This observation suggests that a single neural locus for all aspects of lexical retrieval and its associated phonological assembly and articulatory processes is unlikely. Instead, different parts of a large-scale neural network appear to be implicated in different aspects of lexical retrieval during naming. The lexical retrieval component of naming is known to be quite complex. Retrieval may involve selecting the correct name from among many possible choices in semantic memory that are equally accurate because they label objects with overlapping features. This appears to be a component of retrieval associated with the left lateral temporal cortex that is compromised across AD, FTD and CBD groups (as noted above). Other components of retrieval include, but are not limited to, inhibiting names that share many phonological features but do not name the target object, translating a material-neutral representation of the name into a materialspeci®c form that can be expressed in a speci®c modality, and assembling phonological or graphemic components into a speci®c word that can be expressed. An impairment in any of these subcomponents could interfere with the retrieval component of naming.
Consider in this context the SD subgroup of patients with FTD. In the present study, a direct correlation between confrontation naming dif®culty and cortical volume suggested that a lateral region of the left temporal lobe contributes to naming dif®culty in SD. This left lateral temporal area also had statistically signi®cant cortical atrophy, so it is reasonable to infer that the correlation between naming dif®culty and cortical volume involving this area re¯ects an interruption of a large-scale neural network for naming, and particularly the lexical retrieval component of naming. While we observed cortical atrophy in the left anterior temporal region in SD similar to previous studies (Laakso et al., 2000; Mummery et al., 2000; Chan et al., 2001; Galton et al., 2001; Rosen et al., 2002a) , we did not ®nd a direct correlation between confrontation naming and grey matter volume in this region of the left temporal lobe. This differs from other work that has implicated the left anterior temporal area in naming dif®culty. One correlation study related left anterior temporal cortical atrophy to naming dif®culty in a combined group of patients with SD and AD , but correlation data in each individual group were not reported. A longitudinal study related retrieval to left temporal atrophy in SD (Lambon , but anatomically detailed correlative data were not provided. In a functional neuroimaging study of lexical comprehension in patients with SD, limited activation was observed in lateral portions of left temporal cortex (Mummery et al., 1999) . The authors attributed the comprehension dif®culty in SD to a disconnection within the left temporal lobe between the anterior temporal and lateral temporal structures. In the present study, we cannot rule out that atrophy in the left anterior temporal cortex makes an indirect contribution to the compromised naming process in SD through interruption of connectivity in the left temporal lobe. Indeed, the left anterior temporal region was implicated in the naming de®cits of the larger group of FTD patients that includes this SD subgroup, and it may be that we failed to ®nd a left anterior temporal correlation in the SD subgroup of this study because of the small number of participants. We also observed a correlation between naming and the right lateral temporal cortex, although this portion of the right temporal cortex was not signi®cantly atrophic in SD. The right temporal cortex has been implicated in the semantic component of naming , but in patients who are more severely impaired than the SD patients in the present study. In sum, a retrieval component of naming associated with left lateral temporal cortex appears to be interrupted in patients with SD, and this may involve selection of a target from semantic memory.
Patients with PNFA also have confrontation naming dif®culty (Grossman et al., 1996b; . Observations in this study are consistent with previous work associating the naming impairment in PNFA with limited lexical retrieval (P. Moore, K. Dennis and M. Grossman, unpublished data). In the present study, PNFA patients showed a unique correlation between naming and cortical volume in several left frontal brain regions. Since these regions correspond to areas of statistically signi®cant grey matter atrophy, we suspect that these areas play a role in the naming dif®culty of PNFA patients. Despite the association of these anatomical regions with lexical retrieval in PNFA, these correlations do not involve the same anatomical distribution as in SD and NON-APH subgroups. Left frontal correlations between naming and cortical volume in areas of signi®cant left frontal cortical atrophy in PNFA are thus likely to re¯ect the fact that several distinct components of lexical retrieval can be interrupted during confrontation naming in neurodegenerative diseases. Consistent with previous work (Grossman et al., 1996b (Grossman et al., , 1998 , areas of naming-cortical correlation that also showed statistically signi®cant cortical atrophy in the present study were in the inferior and orbital frontal cortex of the left hemisphere. The left inferior frontal cortex has been implicated in confrontation naming in functional neuroimaging studies of healthy adults (Simon et al., 2002; Whatmough et al., 2002; Burgund et al., 2003) . Several functional neuroimaging studies have hypothesized that the left inferior frontal cortex plays a role in the retrieval process Tulving et al., 1994; Demb et al., 1995; Poldrack et al., 1999) , although the precise nature of this role is a subject of debate. Some studies suggest that the inferior frontal cortex is important for resolving competition between equally probable candidate targets during lexical retrieval (ThompsonSchill et al., 1997) , while others emphasize the controlled nature of lexical retrieval (Wagner et al., 2001) . Studies of brain-damaged patients (Freedman et al., 1998) and functional neuroimaging studies of healthy adults (Taylor et al., 1997; Jonides et al., 1998; Nobre et al., 1999; Rogers et al., 1999) suggest that these areas play an important role in inhibitory control. Neuropsychological studies suggest that PNFA patients have some dif®culty with measures such as the Stroop test that depend in part on inhibitory control (Grossman et al., 1996b; Grossman et al., in press ). Another approach associates the left inferior frontal cortex with phonemic discrimination (Zatorre et al., 1996; Poldrack et al., 1999 Poldrack et al., , 2001 . It is possible to speculate that left inferior frontal regions contribute to naming by helping to select among candidate names that are phonologically and/or semantically similar to the target.
We also found naming-volume correlations in premotor and dorsolateral prefrontal regions of the left frontal lobe in PNFA. Behavioural studies of brain-damaged patients (Perry and Hodges, 1999; Thompson-Schill et al., 1999) and functional neuroimaging studies of healthy adults (Braver et al., 1997; Jonides et al., 1997; Sylvester et al., 2003) emphasize the contribution of these regions to executive resources such as verbal working memory and the development of strategies to augment lexical search. Neuropsychological studies have shown that PNFA patients also have working memory limitations (Grossman et al., 1996b; Rhee et al., 2001) . It is possible that working memory contributes to confrontation naming during the extended process of searching the mental lexicon for a target word.
In NON-APH patients, a correlation between naming and cortical volume in an area of statistically signi®cant cortical atrophy was found in the right dorsolateral prefrontal cortex. This distribution of disease has been seen in previous imaging studies of these patients (Miller et al., 1993; Rosen et al., 2002a) . The role of this brain region in naming is not clear. Activation studies of healthy adults have also recruited the right prefrontal cortex during spatial working memory challenges (Jonides et al., 1993; Courtney et al., 1996; Smith et al., 1996; Braver et al., 1997; Grady et al., 1998; Reuter-Lorenz et al., 2000) and this may work together with the right temporal cortex to limit the scope of the search for a target.
PNFA and NON-APH patients also showed a correlation between grey matter volume and naming dif®culty in the left anterior temporal cortex. The precise role of the left anterior temporal cortex in confrontation naming is unclear. Previous observations of left anterior temporal atrophy in SD suggested that this brain region may contribute to semantic memory (Mummery et al., 2000; Chan et al., 2001; Galton et al., 2001) . Although mild PNFA patients are not known to have signi®cant semantic dif®culty for nouns and objects (Croot et al., 1998; Grossman et al., 1996b; , they appear to be impaired in their comprehension of verbsÐa de®cit associated with disease in inferior frontal cortex (Bak et al., 2001; Rhee et al., 2001) . NON-APH patients may have dif®culty with the comprehension of social knowledge (Wood and Grafman, 2003) . We cannot rule out the possibility that the left anterior temporal cortex plays an indirect role in lexical retrievalÐmediated in part by a disconnection of reciprocal projections in the uncinate fasciculus between the inferior frontal cortex and the anterior temporal cortex. Although we may not be able to specify the precise components of lexical retrieval and associated processes that are compromised in each subgroup of patients with FTD, the association of impaired lexical retrieval with different neuroanatomical distributions of cortical atrophy across these subgroups suggests that a large-scale neural network for naming is interrupted in several different ways that can compromise different facets of lexical retrieval and associated downstream processes during naming.
We are not aware of previous VBM studies of atrophy in CBD. Relative to healthy seniors, CBD patients showed extensive cortical atrophy in a parietal distribution bilaterally. We also observed frontal and temporal cortical atrophy in CBD. CBD is reported to be dif®cult to diagnose accurately (Litvan et al., 1997) and the great variety of clinical manifestations seen in these patients may be due to the widely distributed disease evident at autopsy in CBD (Bergeron et al., 1996; Boeve et al., 1999; Forman et al., 2002) .
We noted above the association of the lexical retrieval component of naming dif®culty with left lateral temporal atrophy found in all patients, including patients with CBD. A signi®cant naming-cortical correlation in CBD was also seen in the left frontal cortex. The left frontal cortex in this distribution is often associated with verbal working memory and other measures of executive functioning, as noted above in our discussion about PNFA. Although we did not assess this cognitive domain in the present study, executive dif®culties such as limited working memory have been demonstrated in patients with CBD (Pillon et al., 1995; Pillon and Dubois, 2000) . It is conceivable that verbal working memory plays a role in mental search aspects of the lexical retrieval component of naming that is compromised in CBD.
The naming de®cit in CBD also correlated uniquely with impaired performance on a measure of visual perceptual± spatial functioning. At least two cortical areas may play a role in the visual perceptual±spatial component of impaired naming in CBD. First, we observed a naming-volume correlation in the right temporal cortex in CBD that corresponded to an area of signi®cant cortical atrophy in these patients. The right ventral temporal cortex may also contribute to a visual perceptual±spatial component of naming in CBD, particularly given the association of this brain region with the ventral stream of visual±perceptual processing (Ungerleider and Mishkin, 1982; Haxby et al., 1991; Grady et al., 1992; Horwitz et al., 1992) . Secondly, our visual perceptual±spatial measure also involved a considerable organizational element, corresponding to an executive component of visual functioning. Previous work has also demonstrated the contribution of the right frontal cortex to visual±perceptual processing. For example, studies of stroke patients and functional MRI studies of healthy subjects have associated the right frontal cortex with executive resources such as visual working memory (Butters et al., 1970; Jonides et al., 1993; Courtney et al., 1996; Smith et al., 1996; Braver et al., 1997; Grady et al., 1998; Reuter-Lorenz et al., 2000) and selective attention (Corbetta et al., 1993; Coull et al., 1996) . In the present study, we also observed a signi®cant correlation between confrontation naming and cortical volume in the right frontal cortex in CBD, which corresponded to an area of signi®cant cortical atrophy in these patients. This may contribute to the working memory needed to appreciate a visual stimulus.
Conclusion
These evaluations suggest that a large-scale neural network underlies naming, and that interruption of this large-scale network occurs in a manner that is partially shared and partially unique to these neurodegenerative diseases. An area of left lateral temporal cortical atrophy is shared across these neurodegenerative diseases and thus appears to contribute to the lexical retrieval component of naming that is impaired in AD, FTD and CBD. The left lateral temporal cortex may play a role in selecting an abstract representation of a name that corresponds to a concept in semantic memory. Lexical retrieval is a complex process, moreover, and other brain regions may contribute to different components of retrieval and associated downstream processes. For example, ventrolateral portions of the left frontal cortex may contribute to selection during the retrieval process (possibly mediating inhibitory control or phonological assembly), while dorsolateral portions of the left frontal cortex may support verbal working memory and mental search strategies during the lexical retrieval process. The right lateral temporal cortex may help limit the scope of the mental search for a target name. Other components of the naming process are also selectively compromised in these patients. Interpretation of the visual perceptual±spatial properties of a stimulus appears to be associated with the right inferolateral temporal and right dorsolateral frontal cortices, and semantic memory may be related in part to speci®c aspects of the temporal cortex. Some of these features can be detected clinically, yielding distinct patterns of naming dif®culty that may be helpful in clinical situations such as differential diagnosis. The patterns of correlation between naming dif®culty and cortical atrophy suggest several additional ways in which the large-scale neural network for naming may be interrupted without obvious behavioural manifestations.
